Alon Ben David

Israel Institute for Biological Research

Papers

Total Citations

H-Index

About

Alon Ben David is a leading researcher in the field of biodefense and neurotoxinology, with a primary focus on botulinum neurotoxins (BoNT)—among the most lethal substances known. His work centers on developing advanced antibody-based countermeasures against botulism, a potentially fatal paralytic disease caused by BoNT serotypes A, B, and E. Ben David’s most cited study (2014, 27 citations) investigates the synergistic neutralizing effects of oligoclonal antibody preparations, addressing a critical gap in current treatments that rely on polyclonal antibodies. By demonstrating how precisely engineered antibody cocktails can enhance neutralization potency and breadth, his research has paved the way for more effective and safer therapeutic strategies. This work is particularly notable for its potential to replace traditional equine-derived antitoxins, reducing side effects and improving accessibility. Beyond this landmark paper, Ben David’s contributions have advanced our understanding of antibody engineering for complex toxins, earning him recognition as a key figure in translational biodefense research. His findings continue to inform the development of next-generation medical countermeasures against biological threats.